CTLA4 and colorectal carcinoma: The m6a-modified circQSOX1 promotes PGAM1 expression by sequestering miR-326 and miR-330-5p, thus activating glycolysis and impairing the response to anti-CTLA-4 therapy, ultimately leading to immune evasion in CRC.